Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

[HCI-BCM] [PDX] [HCI-005] Breast Paget Disease

ABSTRACT:

SUBMITTER:

PROVIDER: S-CMO2766 | biostudies-other |

REPOSITORIES: biostudies-other

ACCESS DATA

Json Xml

Similar Datasets

The Androgen Receptor is a Tumor Suppressor in Estrogen Receptor Positive Breast Cancer [PDX model HCI-005 ChIP-seq]

Project description:The role of the androgen receptor (AR) in estrogen receptor alpha (ER) positive breast cancer is controversial, constraining implementation of AR-directed therapies. Using a diverse, clinically relevant panel of cell-line and patient-derived models, we demonstrate that AR activation, not suppression, exerts potent anti-tumor activity in multiple disease contexts, including resistance to standard-of-care ER and CDK4/6 inhibitors. Importantly, AR agonists combined with standard-of-care agents enhanced therapeutic responses. Mechanistically, agonist activation of AR altered the genomic distribution of ER and essential co-activators (p300, SRC-3), resulting in repression of ER-regulated cell cycle genes and up-regulation of AR target genes, including known tumor suppressors. A gene signature of AR activity positively predicted disease survival in multiple clinical ER+ breast cancer cohorts. These findings provide unambiguous evidence that AR has a tumor suppressor role in ER+ breast cancer and support AR agonism as the optimal AR-directed treatment strategy, revealing a rational therapeutic opportunity.

2021-01-18 | GSE129930 | GEO

The Androgen Receptor is a Tumor Suppressor in Estrogen Receptor Positive Breast Cancer [PDX model HCI-005 & GAR15-13 RNA-seq]

2021-01-18 | GSE123763 | GEO

[HCI-BCM] [PDX] [HCI-007] Breast Paget Disease

Project description: Not available

| S-CMO2826 | biostudies-other

[HCI-BCM] [PDX] [HCI-006] Breast Paget Disease

Project description: Not available

| S-CMO2813 | biostudies-other

Multiome analysis of PDxOs (HCI-003, HCI-005, HCI-011) treated with a CDK4/6 inhibitor for 3 weeks

Project description:This study uses single-nucleus multiome profiling, as well as bulk methylation profiling, to characterize the transcriptional, chromatin accessibility, and DNA methylation changes after 3 weeks of CDK4/6 inhibitor treatment in organoids grown from patient-derived xenograft tumors (PDxOs) generated from 3 patients: HCI-003, HCI-005, and HCI-011.

2026-07-13 | GSE338025 | GEO

HCI-PDX Trial Center for Breast Cancer Therapy

Project description:HCI-PDX Trial Center for Breast Cancer Therapy

| PRJNA741291 | ENA

HCI-PDX Trial Center for Breast Cancer Therapy

Project description:HCI-PDX Trial Center for Breast Cancer Therapy

| PRJNA741292 | ENA

[HCI-BCM] [PDX] [BCM-0002] Breast Adenocarcinoma

Project description: Not available

| S-CMO2777 | biostudies-other

[HCI-BCM] [PDX] [BCM-3613] Breast Adenocarcinoma

Project description: Not available